News & Updates

There is no convincing benefit to consuming a bedtime snack for glycaemic control in individuals with type 2 diabetes (T2D) or prediabetes, according to the results of a systematic review.

In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.

Utility of pituitary transcription factors (TFs) improves the diagnostic accuracy and prognostication of nonfunctioning pituitary neuroendocrine tumours (NF-PitNETs), according to local data and a new diagnostic classification presented at the 5^th Annual Meeting of Endocrinology, Diabetes & Metabolism Hong Kong (EDM HK).

Vegan and vegetarian diets that are low in carbohydrates reduce body weight as well as improve glycaemic control and blood pressure in individuals with type 2 diabetes (T2D), suggests a study, adding that a plant-based diet shows greater potential decrease in greenhouse gas emissions.

Use of glucagon-like peptide 1 (GLP-1) receptor agonists or sodium-glucose co-transporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, helps prevent severe exacerbations of chronic obstructive pulmonary disease (COPD) in patients with type 2 diabetes (T2D), a UK study has shown.

Crucial gaps remain between the perspectives of patients living with type 2 diabetes and healthcare providers, a recent study has found.